4//SEC Filing
Trier Clayton 4
Accession 0001209191-21-038140
CIK 0000885978other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 12:10 PM ET
Size
8.5 KB
Accession
0001209191-21-038140
Insider Transaction Report
Form 4
Trier Clayton
Director
Transactions
- Sale
Common Stock
2021-06-03$119.95/sh−27$3,239→ 9,034 total - Sale
Common Stock
2021-06-02$119.92/sh−2,419$290,086→ 9,061 total - Sale
Common Stock
2021-06-03$119.62/sh−54$6,459→ 8,980 total
Footnotes (2)
- [F1]The price reported is a weighted average price ($119.92). The shares were sold in multiple transactions at prices ranging from $119.91 to $119.99 per share, inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
- [F2]Includes 1,480 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares on each of July 1, 2021, October 1, 2021, January 1, 2022 and April 1, 2022, if he is a director of the Company on those dates.
Documents
Issuer
U S PHYSICAL THERAPY INC /NV
CIK 0000885978
Entity typeother
Related Parties
1- filerCIK 0001319561
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 12:10 PM ET
- Size
- 8.5 KB